Hypercalcemia in patients with metastatic renal cell carcinoma: Effect of nephrectomy and metabolic evaluation

Journal of Urology

Volumn 158, Issue 3, 1997, Pages 733-739

  Walther, Mcclellan M ^a   Patel, Biren ^a   Choyke, Peter L ^a   Lubensky, Irina A ^a   Vocke, Cathy D ^a   Harris, Cynthia ^a   Venzon, David ^a   Burtis, William J ^a   Linehan, W Marston ^a  

^a NONE

Author keywords

Carcinoma; Hypercalcemia; Neoplasm metastasis; Parathyroid hormones; Renal cell; Surgery

Indexed keywords

PARATHYROID HORMONE; PARATHYROID HORMONE RELATED PROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; HORMONAL REGULATION; HUMAN; HYPERCALCEMIA; HYPERPARATHYROIDISM; KIDNEY CARCINOMA; MALE; NEPHRECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT OUTCOME;

EID: 0030854893     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)64303-9     Document Type: Article

References (49)

1. Mundy, G. R. and Martin, T. J.: The hypercalcemia of malignancy: pathogenesis and management. Metabolism, 31: 1247, 1982.
2. Fahn, H. -J., Lee, Y. -H., Chen, M. -T., Huang, J. -K., Chen, K. -K. and Chang, L. S.: The incidence and prognostic significance of humoral hypercalcemia in renal cell carcinoma. J. Urol., 145: 248, 1991.
3. Chasan, S. A., Pothel, L. R. and Huben, R. P.: Management and prognostic significance of hypercalcemia in renal cell carcinoma. Urology, 33: 167, 1989.
4. Omenn, G. S., Roth, S. I. and Baker, W. H.: Hyperparathyroidism associated with malignant tumors of nonparathyroid origin. Cancer, 24: 1004, 1969.
5. Weir, E. C., Insogna, K. L., Brownstein, D. G., Bander, N. H. and Broadus, A. E.: In vitro adenylate cyclase-stimulating activity predicts the occurrence of humoral hypercalcemia of malignancy in nude mice. J. Clin. Invest., 81: 818, 1988.
6. Stewart, A. F., Horst, R., Deftos, L. J., Cadman, E. C., Lang, R. and Broadus, A. E.: Biochemical evaluation of patients with cancer-associated hypercalcemia: evidence for humoral and nonhumoral groups. New Engl. J. Med., 303: 1377, 1980.
7. Godsall, J. W., Burtis, W. J., Insogna, K. L., Broadus, A. E. and Stewart, A. F.: Nephrogenous cyclic AMP, adenylate cyclase-stimulating activity, and the humoral hypercalcemia of malignancy. Recent Prog. Horm. Res., 42: 705, 1986.
8. Benson, R. C., Jr., Riggs, B. L., Pickard, B. M. and Arnaud, C. D.: Radioimmunoassay of parathyroid hormone in hypercalcemic patients with malignant disease. Amer. J. Med., 56: 821, 1974.
9. Tsuchihashi, T., Yamaguchi, K., Miyake, Y., Otsubo, K., Nagasaki, K., Honda, S., Akiyama, Y., Maeda, Y., Koike, M., Alper, O., et al.: Parathyroid hormone-related protein in tumor tissues obtained from patients with humoral hypercal calcemia of malignancy. J. Nat. Cancer Inst., 82: 40, 1990.
10. Burtis, W. J., Brady, T. G., Orloff, J. J., Ersbak, J. B., Warrell, R. P., Jr., Olson, B. R., Wu, T. L., Mitnik, M. E., Broadus, A. E. and Stewart, A. F.: Immunochemical characterization of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of cancer. New Engl. J. Med., 322: 1106, 1990.
11. Budayr, A. A., Nissenson, R. A., Klein, R. F., Pun, K. K., Clark, O. H., Diep, D., Arnaud, C. D. and Strewler, G. J.: Increased serum levels of a parathyroid hormone-like protein in malignancy-associated hypercalcemia. Ann. Intern. Med., 111: 807, 1989.
12. Thiede, M. A. and Rodan, G. A.: Expression of a calcium-mobilizing parathyroid hormone-like peptide in lactating mammary tissue. Science, 242: 278, 1988.
13. Kao, P. C., Klee, G. G., Taylor, R. L. and Heath, H., III: Parathyroid hormone-related peptide in plasma of patients with hypercalcemia and malignant lesions. Mayo Clin. Proc., 65: 1399, 1990.
14. Henderson, J. E., Shustik, C., Kremer, R., Rabbani, S. A., Hendy, G. N. and Goltzman, D.: Circulating concentrations of parathyroid hormone-like peptide in malignancy and in hyperparathyroidism. J. Bone Miner. Res., 5: 105, 1990.
15. Insogna, K. L. and Broadus, A. E.: Hypercalcemia of malignancy. Ann. Rev. Med., 38: 241, 1987.
16. Broadus, A. E., Mangin, M., Ikeda, K., Insogna, K. L., Weir, E. C., Burtis, W. J. and Stewart, A. F.: Humoral hypercalcemia of cancer: identification of a novel parathyroid hormone-like peptide. New Engl. J. Med., 319: 556, 1988.
17. Schilling, T., Pecherstorfer, M., Blind, E., Leidig, G., Ziegler, R. and Raue, F.: Parathyroid hormone-related protein (PTHrP) does not regulate 1,25-dihydroxyvitamin D serum levels in hypercalcemia of malignancy. J. Clin. Endocr. Metab., 76:801, 1993.
18. Walther, M. M., Alexander, R. B., Weiss, G. H., Venzon, D., Berman, A., Pass, H. I., Linehan, W. M. and Rosenberg, S. A.: Cytoreductive surgery prior to interleukin-2-based therapy in patients with metastatic renal cell carcinoma. Urology, 42: 250, 1993.
19. Payne, R. B., Carver, M. E. and Morgan, D. B.: Interpretation of serum total calcium: effects of adjustment for albumin concentration on frequency of abnormal values and on detection of change in the individual. J. Clin. Path., 32: 56, 1979.
20. Payne, R. B., Little, A. J., Williams, R. B. and Milner, J. R.: Interpretation of serum calcium in patients with abnormal serum proteins. Brit. Med. J., 4: 643, 1973.
21. Baltarowich, O. H.: Female pelvic organ measurements. In: Atlas of Ultrasound Measurements. Edited by B. B. Goldberg and A. B. Kurtz. Chicago: Year Book Publishers, chapt. 19, p. 190, 1990.
22. Brown, P. D., Levy, A. T., Margulies, I. M., Liotta, L. A. and Stetler-Stevenson, W. G.: Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines. Cancer Res., 50: 6184, 1990.
23. Thiede, M. A., Strewler, G. J., Nissenson, R. A., Rosenblatt, M. and Rodan, G. A.: Human renal cell carcinoma expresses two messages encoding a parathyroid hormone-like peptide: evidence for the alternative splicing of a single-copy gene. Proc. Nat. Acad. Sci., 85: 4605, 1988.
24. Walther, M. M., Gnarra, J. R., Elwood, L., Xu, H. -J., Florence, C., Anglard, P., Hu, S. -X., King, C., Trahan, E., Hurley, K., Sens, D., Venzon, D., Liu, S., Jaffe, G. S., Benedict, W. F. and Linehan, W. M.: Loss of heterozygosity occurs centromeric to RB without associated abnormalities in the retinoblastoma gene in tumors from patients with metastatic renal cell carcinoma. J. Urol., 153: 2050, 1995.
25. Reiter, R. E., Anglard, P., Liu, S., Gnarra, J. R. and Linehan, W. M.: Chromosome 17p deletions and p53 mutations in renal cell carcinoma. Cancer Res., 53: 3092, 1993.
26. Gnarra, J. R., Tory, K., Weng, Y., Schmidt, L., Wei, M. H., Li, H., Latif, F., Liu, S., Chen, F., Duh, F. -M., Lubensky, I., Duan, D. -S., Florence, C., Pozatti, R., Walther, M. M., Bander, N. H., Grossman, H. B., Brauch, H., Isaacs, W. B., Lerman, M. I., Zbar, B. and Linehan, W. M.: Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat. Gen., 7: 85, 1994.
27. Xu, H. J., Hu, S. X., Cagle, P. T., Moore, G. E. and Benedict, W. F.: Absence of retinoblastoma protein expression in primary non-small cell lung carcinomas. Cancer Res., 51: 2735, 1991.
28. Mangin, M., Ikeda, K., Dreyer, B. E., Milstone, L. and Broadus, A. E.: Two distinct tumor-derived, parathyroid hormone-like peptides result from alternative ribonucleic acid splicing Mol. Endocrinol., 2: 1049, 1988.
29. Mangin, M., Webb, A. C., Dreyer, B. E., Posillico, J. T., Ikeda, K., Weir, E. C., Stewart, A. F., Bander, N. H., Milstone, L., Barton, D. E. et al.: Identification of a cDNA encoding a parathyroid hormone-like peptide from a human tumor associated with humoral hypercalcemia of malignancy. Proc. Natl. Acad. Sci., 85: 597, 1988.
30. Gotoh, A., Kitazawa, S., Mizuno, Y., Takenaka, A., Arakawa, S., Matsumoto, O., Kitazawa, R., Fujimori, T., Maeda, S. and Kamidono, S.: Common expression of parathyroid hormone-related protein and no correlation of calcium level in renal cell carcinomas. Cancer, 71: 2803, 1993.
31. Hughes, T. E. and Hansen, L. A.: Gallium nitrate. Ann. Pharmacother., 26: 354, 1992.
32. Walls, J., Ratcliffe, W. A., Howell, A. and Bundred, N. J.: Response to intravenous bisphosphonate therapy in hypercalcaemic patients with and without bone metastases: the role of parathyroid hormone-related protein. Brit. J. Cancer, 70: 169, 1994.
33. Wimalawansa, S. J.: Significance of plasma PTH-rp in patients with hypercalcemia of malignancy treated with bisphosphonate. Cancer, 73: 2223, 1994.
34. Powell, D., Singer, F. R., Murray, T. M., Minkin, C. and Potts, J. T., Jr.: Nonparathyroid humoral hypercalcemia in patients with neoplastic diseases. New Engl. J. Med., 289: 176, 1973.
35. Yates, A. J., Gutierrez, G. E., Smolens, P., Travis, P. S., Katz, M. S., Aufdemorte, T. B., Boyce, B. F., Hymer, T. K., Poser, J. W. and Mundy, G. R.: Effects of a synthetic peptide of a parathyroid hormone-related protein on calcium homeostasis, renal tubular calcium reabsorption, and bone metabolism in vivo and in vitro in rodents. J. Clin. Invest., 81: 932, 1988.
36. Ikeda, K., Mangin, M., Dreyer, B. E., Webb, A. C., Posillico, J. T., Stewart, A. F., Bander, N. H., Weir, E. C., Insogna, K. L. and Broadus, A. E.: Identification of transcripts encoding a parathyroid hormone-like peptide in messenger RNAs from a variety of human and animal tumors associated with humoral hypercalcemia of malignancy. J. Clin. Invest., 81: 2010, 1988.
37. Mune, T., Katakami, H., Kato, Y., Yasuda, K., Matsukura, S. and Miura, K.: Production and secretion of parathyroid hormone-related protein in pheochromocytoma: participation of an alpha-adrenergic mechanism. J. Clin. Endocr. Metab., 76: 757, 1993.
38. Ikeda, K., Weir, E. C., Mangin, M., Dannies, P. S., Kinder, B., Deftos, L. J., Brown, E. M. and Broadus, A. E.: Expression of messenger ribonucleic acids encoding a parathyroid hormone-like peptide in normal human and animal tissues with abnormal expression in human parathyroid adenomas. Mol. Endocrinol., 2: 1230, 1988.
39. Demers, L. M., Allegra, J. C., Harvey, H. A., Lipton, A., Luderer, J. R., Mortel, R. and Brenner, D. E.: Plasma prostaglandins in hypercalcemic patients with neoplastic disease. Cancer, 39: 1559, 1977.
40. Bringhurst, F. R., Bierer, B. E., Godeau, F., Neyhard, N., Varner, V. and Segre, G. V.: Humoral hypercalcemia of malignancy. Release of a prostaglandin-stimulating bone-resorbing factor in vitro by human transitional-cell carcinoma cells. J. Clin. Invest., 77: 456, 1986.
41. Greaves, M., Ibbotson, K. J., Atkins, D. and Martin, T. J.: Prostaglandins as mediators of bone resorption in renal and breast tumours. Clin. Sci., 58: 201, 1980.
42. Brenner, D. E., Harvey, H. A., Lipton, A. and Demers, L.: A study of prostaglandin E2, parathormone, and response to indomethacin in patients with hypercalcemia of malignancy. Cancer, 49: 556, 1982.
43. Brereton, H. D., Halushka, P. V., Alexander, R. W., Mason, D. M., Keiser, H. R. and DeVita, V. T., Jr.: Indomethacin-responsive hypercalcemia in a patient with renal-cell adenocarcinoma. New Engl. J. Med., 291: 83, 1974.
44. Jung, A., Millet, R., Schneider, P. and Walton, R. J.: Hypercalcaemia and parathyroid hyperplasia associated with renal adenocarcinoma. Postgrad. Med. J., 52: 106, 1976.
45. Castleman, B., Scully, R. E. and McNeely, B. U.: Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 34-1972. New Engl. J. Med., 287: 401, 1972.
46. O'Grady, A. S., Morse, L. J. and Lee, J. B.: Parathyroid hormone-secreting renal carcinoma associated with hypercalcemia and metabolic alkalosis. Ann. Int. Med., 63: 858, 1965.
47. Vail, A. D. and Coller, F. C.: The parathyroid glands: clinicopathologic correlation of parathyroid disease as found in 200 unselected autopsies. Mod. Med., 64: 234, 1967.
48. Pecherstorfer, M., Schilling, T., Blind, E., Zimmer-Roth, I., Baumgartner, G., Ziegler, R. and Raue, F.: Parathyroid hormone-related protein and life expectancy in hypercalcemic cancer patients. J. Clin. Endocrinol. Metab., 78: 1268, 1994.
49. Gurney, H., Grill, V. and Martin, T. J.: Parathyroid hormone-related protein and response to pamidronate in tumour-induced hypercalcaemia. Lancet, 341: 1611, 1993.